How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | EMNEASTMAN CHEMICAL CO | RPMRPM INTERNATIONAL INC/DE/ | ALBALBEMARLE CORP | SOLSSolstice Advanced Materials Inc. | Median of the restexcluding EMN |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $65.31▲ 1.81 (2.85%) | $101.72▲ 1.84 (1.84%) | $92.54▼ 1.93 (2.04%) | $64.99▲ 1.93 (3.06%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 8.0/10 | 4.0/10 | 7.0/10 | 7.0/10 |
| Market value | $14.63B | $12.98B | $10.89B | $10.32B | |
| Revenue | $8.75B | $7.86B | $5.14B | $3.89B | |
| Profit | $474.0M | $661.4M | -$510.6M | $237.0M | |
| Revenue growthChange in sales versus the prior year. | -6.7% | 6.7% | -4.4% | 3.1% | 3.1% |
| Gross marginShare of sales left after the direct cost of producing them. | 21.1% | 41.4% | 13.0% | 32.2% | 32.2% |
| Operating marginShare of sales left after running the business, before interest and tax. | — | — | -7.1% | — | -7.1% |
| Profit marginProfit kept from each dollar of sales. | 5.4% | 8.4% | -9.9% | 6.1% | 6.1% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 4.8% | 8.6% | 13.5% | 3.1% | 8.6% |
| Return on equityProfit against the owners' stake in the company. | 8.0% | 20.0% | -5.4% | 16.8% | 16.8% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | — | -2.6% | — | -2.6% |
| P/E ratioPrice paid per dollar of annual profit. | 30.86x | 19.63x | — | 43.53x | 31.58x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | 42.76x | — | 42.76x |
| Price to book | 2.45x | 3.92x | 1.14x | 7.31x | 3.92x |
| Debt to equityTotal liabilities compared with owners' stake. | 1.48x | 1.52x | 0.72x | 3.04x | 1.52x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 5/9 | 6/9 | 6/9 | 4/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | not reported | safe | distress | grey |
How EMN compares with the others
- EMN's profit margin of 5.4% is in line with the median of the other companies selected (6.1%).
- Its revenue grew more slowly than the median of the other companies selected: -6.7% against 3.1%.
- It trades at a P/E in line with the median of the other companies selected (30.9x against 31.6x).
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.